22.418 articles found

Role of tolcapone in the treatment of Parkinson's disease.

Leegwater-Kim J, Waters C.

Expert Rev Neurother · 2007-12-01

DOI: 10.1586/14737175.7.12.1649PMID: 18052761

Kinase signaling pathways as potential targets in the treatment of Parkinson's disease.

Greggio E, Singleton A.

Expert Rev Proteomics · 2007-12-01

DOI: 10.1586/14789450.4.6.783PMID: 18067416

Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Ann N Y Acad Sci · 2007-12-01

DOI: 10.1196/annals.1403.011PMID: 18077571

Treatment of neurodegenerative disorders with radical nanomedicine.

Singh N, Cohen CA, Rzigalinski BA.

Ann N Y Acad Sci · 2007-12-01

DOI: 10.1196/annals.1403.015PMID: 18077575

Catheter ablation therapy for supraventricular arrhythmias.

Marine JE.

JAMA · 2007-12-01

DOI: 10.1001/jama.298.23.2768PMID: 18165670

Utilization of Ayurveda in health care: an approach for prevention, health promotion, and treatment of disease. Part 2--Ayurveda in primary health care.

Sharma H, Chandola HM, Singh G, Basisht G.

J Altern Complement Med · 2007-12-01

DOI: 10.1089/acm.2007.7017-bPMID: 18166127

Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment.

Kim HJ, Chatani E, Goto Y, Paik SR.

J Microbiol Biotechnol · 2007-12-01

PMID: 18167451

Is alpha-synuclein pathology a target for treatment of neurodegenerative disorders?

Windisch M, Wolf HJ, Hutter-Paier B, Wronski R.

Curr Alzheimer Res · 2007-12-01

DOI: 10.2174/156720507783018343PMID: 18220522

Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin.

Morgenthaler TI, Kapur VK, Brown T, Swick TJ, Alessi C, Aurora RN, Boehlecke B, Chesson AL, Friedman L, Maganti R, Owens J, Pancer J, Zak R, Standards of Practice Committee of the American Academy of Sleep Medicine.

Sleep · 2007-12-01

DOI: 10.1093/sleep/30.12.1705PMID: 18246980

Rivastigmine for the treatment of dementia associated with Parkinson's disease.

Reingold JL, Morgan JC, Sethi KD.

Neuropsychiatr Dis Treat · 2007-12-01

DOI: 10.2147/ndt.s1134PMID: 19300613

HERBAL MIXTURE AND ACTIVE SUBSTANCE OBTAINED FROM IT, ITS APPLICATION TO IMPROVE METABOLISM, BOOST IMMUNITY AND HELP IN THERAPY

JUROS ANTE.

· 2007-11-29

Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model.

Li W, Dai S, An J, Li P, Chen X, Xiong R, Liu P, Wang H, Zhao Y, Zhu M, Liu X, Zhu P, Chen JF, Zhou Y.

Neuroscience · 2007-11-28

DOI: 10.1016/j.neuroscience.2007.11.020PMID: 18207647